Towards Developing Greener Methods for Oligonucleotide Synthesis
Time: 5pm Amsterdam - 9 AM MST Date: February 23, 2023 Research: My research focuses on the development of novel methodologies for oligonucleotide synthesis, with a particular emphasis on reducing the solvent footprint of oligonucleotide synthesis. Webinar topic: My webinar will largely focus on ...
Trainee Spotlight Series: OTS 2023 Junior Board Members
Time: 5pm Amsterdam - 9 AM MST Date: February 9, 2023 Speakers: Krystal Johnson, MSc Investigating the consequences of nuclear AGO2 in colon cancer model systems View Bio Description Argonaute proteins ...
Trainee Spotlight Series: OTS 2022 Poster Winners
Time: 5pm Amsterdam - 9 AM MST Date: January 26th, 2023 Topic / Speakers: Quantitative measurement of cytosolic and nuclear penetration of oligonucleotide therapeutics and investigation of sequence-penetration relationships Nefeli Batistatou, MSc Nefeli Batistatou, ...
Delivery of Chemically Stabilized RNAi molecules to the Central Nervous System
Time: 11am - 12pm ESTDate: December 1, 2022 Description: Dr. Godinho will talk about the developments on delivery and PK/PD of novel oligonucleotides for CNS applications Speaker: Bruno M.D.C. Godinho Sr. Scientist Atalanta Therapeutics ...
An insider’s view into the preclinical development of an approved exon skipping drug
Time: 11am - 12pm EST Date: November 3, 2022 Description: Dr. Arechavala works on developing new drugs for neuromuscular disorders. As there are not many for these rare diseases, neuromuscular disorders have been at the forefront of the clinical development of RNA based ...
Site-specific detection of mutagenic DNA damage with an artificial nucleotide
Time: 11am - 12pm EST Date: October 27, 2022 Description: Incorporating nucleotides with altered structures that are derived synthetically is a strategy that has been used widely to interrogate biological processes involving DNA. Particularly, synthetic nucleotides able to stabilize damaged over undamaged templates ...
Patient Advocacy and Therapeutic Development for Huntington’s Disease
Time: 11am - 12pm EST Date: August 11, 2022 Description: Dan O'Reilly, PhD, a former OTS Trainee BoD member, focuses his research on developing siRNA therapeutics for Huntington’s Disease. Join us as Dr. O'Reilly discusses patient advocacy and Huntington’s Disease research. ...
Transitioning from Trainee to Faculty – A conversation with Prof. Bethany Powell Gray
Time: 11am - 12pm EST Date: July 14, 2022 Description: Join us for an open discussion with Dr. Bethany Powell Gray, who is an Assisstant Professor at the John Hopkins University School of Medicine, where we will talk about the postdoc to faculty ...
Trainee Spotlight Series: Yan Li and Roberto El Khoury
Title: Trainee Spotlight Series: Yan Li and Roberto El Khoury Time: 11am EST Date: July 7, 2022 Description: This Trainee Spotlight features Yan Li, a Ph.D. student at the University of California, Los Angeles, and Roberto El Khoury a Ph.D. candidate at McGill ...
Pitfalls and Progress in the Development of Immune Stimulatory Nucleic Acids
Date: June 2, 2022 Time: 11-12 EST Speaker: Art Krieg, MD, Checkmate Pharmaceuticals Description: Art Krieg, MD, CSO at Checkmate Pharmaceuticals, focuses his research on stimulating innate immunity with immune stimulatory DNA and RNA. Join us as Dr. Krieg discusses the history of efforts ...
